Private equity firms now hold 33,575 portfolio companies they have not exited, even as July deal flow climbed to $43.31 billion and sports transactions like the Lakers' $12.5 billion sale suggest appetite remains intact. The inventory problem is valuation, not liquidity. Firms deployed at peak multiples between 2020 and 2022, and the mark-to-market arithmetic no longer supports distributions their LPs will accept.
The overhang is structural. Industry data shows the average holding period stretched to 6.2 years in 2025, up from 4.8 years in 2019. Firms raised $1.2 trillion in fresh commitments during that window and wrote checks into frothy enterprise value multiples—often 12x to 15x EBITDA for software and healthcare assets. Exit markets today price those same businesses at 9x to 11x, absent material margin expansion or revenue acceleration. The math traps capital. LPs who committed at one IRR assumption now face extensions, not exits.
The divergence between deployment and realization sharpens. Brookfield Asset Management and Warburg Pincus moved size in July, but those transactions represent new money entering, not old money leaving. The $12.5 billion Lakers sale went to a strategic consortium, not a financial exit by prior sponsors. Continuation funds and GP-led secondaries have absorbed some pressure—$48 billion in volume through Q2 2025—but those mechanisms recycle exposure rather than returning cash. Family offices and endowments that modeled 10% to 12% annual distributions now receive 4% to 6%, and the gap compounds.
The impact flows to asset allocation and liquidity planning. Principals who assumed private equity stakes would turn inside seven years now hold positions entering year nine or ten. That duration mismatch forces either bridge liquidity draws against other portfolios or acceptance of lower blended returns across the entire book. Fund managers who marketed vintage diversification as risk mitigation now explain why 2020, 2021, and 2022 funds still show unrealized carryover into 2026. The denominator effect—where public market gains make private allocations look overweight—has reversed, leaving many allocators structurally underweight to public equities even as those assets outperform.
Operators should watch three markers over the next eighteen months. First, continuation fund volume in Q4 2025 and Q1 2026—if it exceeds $30 billion per quarter, the exit queue is lengthening, not clearing. Second, the spread between new-deal EBITDA multiples and secondary pricing for similar assets—compression below 1.5x suggests the bid-ask gap is closing. Third, distribution rates from funds vintaged 2020 to 2022 in their Q4 2025 and Q1 2026 reports—any climb above 8% annualized signals selective exits are clearing at acceptable losses.
The 33,575 figure is not a headline. It is a denominator that governs liquidity across every institutional portfolio with private equity exposure.